Boston Millennia Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Boston Millennia Partners has invested in 1 company.

Boston Millennia Partners’ most common sectors for investment arelife science (25%) and software (25%) . The Firm’s most common investment types include venture (57%) and growth capital (38%). In total, Boston Millennia Partners has invested in 10 US states and 2 different countries.

In the last 3 years, Boston Millennia Partners has exited 1 company. The Firm’s most common exit type is trade sale (67%). Boston Millennia Partners’ largest (disclosed) exit occurred in 2004 when it sold ILEX Oncology for $1.0B.

Join Mergr to view Boston Millennia Partners’ full profile and discover more middle-market growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity31
    • M&A Buy Activity16
    • M&A Sell Activity15
  • Total Sectors Invested 8
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 18

Boston Millennia Partners

30 Rowes Wharf, Suite 400,
Boston, Massachusetts 02110
United States
(617) 428-5150
www.bostonmillenniapartners.com

Boston Millenia Partners is a growth capital investment firm focused rapidly growing business services and healthcare companies. The Firm generally looks to invest $3 to $10 million in companies at or near profitability with $3 to $30 million in sales. Boston Millenia's geographic preference is for opportunities in the Eastern half of the US. Boston Millenia Partners was formed in 1984 and has a single office in Boston.


Investment Criteria

Sectors of Interest: Business Services, Consumer Products, Healthcare Services, Information Technology, Internet Software and Services, Life Science, Media, Medical Products, Transportation

Target Transaction Types: Growth Capital, Stake Purchase, Venture

Geographic Preferences: East US, Midwest US, South US

Transaction Criteria Min Max
Target Revenue 3 30
Target EBITDA - -
Investment Size 3 10
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.4/yr) # 14 1 1 - - - 16
Sell (0.6/yr) # 12 2 1 - - - 15
vol $1.6B $1.6B
  31

Most Recent M&A

Company Date Value Type
Forefront Telecare, Inc. 2022-09-01 - Add-on Acquisition
Hamilton, New Jersey · www.forefronttelecare.com
Huma.AI, Inc. 2022-02-08 - Growth Capital
Palo Alto, California · www.huma.ai
BEKHealth Corp. 2021-06-21 - Growth Capital
Kent, Connecticut · www.bekhealth.com
G-Form LLC 2021-04-09 - Secondary Buyout
Providence, Rhode Island · www.g-form.com
Avhana Health, Inc. 2021-01-13 - Add-on Acquisition
Baltimore, Maryland · www.avhana.com
Cota, Inc. 2020-11-10 - Add-on Acquisition
New York, New Jersey · www.cotahealthcare.com
Reveleer, Inc. 2020-01-21 - Venture
Glendale, California · www.reveleer.com
iQuartic, Inc. 2019-05-31 - Add-on Acquisition
Boston, Massachusetts · www.iquartic.com
Forefront Telecare, Inc. 2019-04-24 - Growth Capital
Hamilton, New Jersey · www.forefronttelecare.com
Bivarus, Inc. 2018-01-16 - Add-on Acquisition
Durham, North Carolina · www.bivarus.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science - - 4 (25%) -
Software 3 (60%) - 4 (25%) -
Information Technology 1 (20%) - 2 (13%) -
Medical Products 1 (20%) - 2 (13%) -
Business Services - - 1 (6%) -
Healthcare Services - - 1 (6%) -
Internet Software and Services - - 1 (6%) -
Transportation - - 1 (6%) -
Total 5 - 16 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 4 (80%) - 15 (94%) -
  Massachusetts - - 3 (19%) -
  California 2 (40%) - 2 (13%) -
  Connecticut 1 (20%) - 2 (13%) -
  New Jersey - - 2 (13%) -
  Georgia 1 (20%) - 1 (6%) -
  Washington - - 1 (6%) -
  Texas - - 1 (6%) -
  North Carolina - - 1 (6%) -
  New Hampshire - - 1 (6%) -
  Maryland - - 1 (6%) -
Switzerland 1 (20%) - 1 (6%) -
Total 5 - 16 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 1 (20%) - 9 (56%) -
Growth Capital 3 (60%) - 6 (38%) -
Stake Purchase 1 (20%) - 1 (6%) -
Total 5 - 16 -

Exits by Deal Type

Type Total # Value
Trade Sale 6 (40%) 578M (37%)
Trade Sale - Public Company 4 (27%) 1.0B (63%)
IPO 2 (13%) -
Secondary Sale 2 (13%) -
Merger 1 (7%) -
Total 15 $1.6B

Deal Values

sell # Total
> $1B 1 $1.0B
$100M to $1B 2 $578M
TOTAL $1.6B
Largest ILEX Oncology, Inc.
$1.0B (2004-12-21)

M&A Connections

Deals
Exited to
Investor(s)
13%
2 (13%)
Strategic(s)
73%
11 (73%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Middle-Market

PE Assets

700M USD

Established

1984

Specialist/Generalist

Generalist

Leadership

Dana Callow

Managing Partner

Bruce Tiedemann

CFO

Marty Hernon

General Partner

Ren Roome

Partner

Amy Merk

Director of Administration & Investor Relations

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal